IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

VERZONI, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.307
NA - Nord America 1.612
AS - Asia 1.555
SA - Sud America 123
AF - Africa 67
OC - Oceania 11
Totale 5.675
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.578
DE - Germania 1.239
SG - Singapore 508
CN - Cina 462
GB - Regno Unito 383
VN - Vietnam 197
HK - Hong Kong 160
SE - Svezia 152
IT - Italia 137
RU - Federazione Russa 116
BR - Brasile 92
FR - Francia 89
FI - Finlandia 53
IN - India 52
CI - Costa d'Avorio 47
IE - Irlanda 45
JP - Giappone 37
NL - Olanda 31
KR - Corea 29
ID - Indonesia 22
TR - Turchia 22
CA - Canada 14
AR - Argentina 13
MX - Messico 12
AU - Australia 11
IQ - Iraq 9
UA - Ucraina 9
BD - Bangladesh 8
PL - Polonia 8
AT - Austria 7
MY - Malesia 6
PK - Pakistan 6
BE - Belgio 5
CH - Svizzera 5
EC - Ecuador 5
ES - Italia 5
KE - Kenya 5
TW - Taiwan 5
ZA - Sudafrica 5
CO - Colombia 4
LT - Lituania 4
MA - Marocco 4
IL - Israele 3
NP - Nepal 3
OM - Oman 3
PH - Filippine 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
VE - Venezuela 3
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CG - Congo 2
CL - Cile 2
GR - Grecia 2
JM - Giamaica 2
NO - Norvegia 2
PT - Portogallo 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
IR - Iran 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MM - Myanmar 1
NG - Nigeria 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 5.675
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 1.150
Southend 332
Singapore 292
Ashburn 237
Chandler 195
Hong Kong 150
San Jose 92
Milan 87
Fairfield 82
Beijing 77
Seattle 69
Wilmington 69
Princeton 60
Dallas 57
Munich 54
Council Bluffs 50
Ho Chi Minh City 49
Abidjan 47
Hanoi 47
Dublin 45
New York 45
Los Angeles 40
Houston 36
Woodbridge 34
Lauterbourg 33
Nanjing 33
Cambridge 31
Moscow 28
Shanghai 28
Dearborn 24
Santa Clara 24
Guangzhou 22
Helsinki 22
Bengaluru 20
Buffalo 19
Jakarta 19
Tokyo 19
Columbus 16
Da Nang 16
London 15
Phoenix 15
Istanbul 14
Ann Arbor 13
Cangzhou 13
Des Moines 13
Redwood City 12
São Paulo 12
Eitensheim 11
Haiphong 10
Hefei 9
The Dalles 9
Changsha 8
Chicago 8
Hangzhou 8
Shenyang 8
Shenzhen 8
Tianjin 8
Toronto 8
Fuzhou 7
Hebei 7
Jinan 7
Seoul 7
Turku 7
Nanchang 6
Silver Spring 6
Wuhan 6
Zhengzhou 6
Chennai 5
Hyderabad 5
Jiaxing 5
Johannesburg 5
Kuala Lumpur 5
Quảng Ngãi 5
San Diego 5
San Francisco 5
Bogotá 4
Brussels 4
Fremont 4
Mexico City 4
Nha Trang 4
Norwalk 4
Taiyuan 4
Vienna 4
Warsaw 4
Zurich 4
Amsterdam 3
Baghdad 3
Berlin 3
Biên Hòa 3
Boardman 3
Brooklyn 3
Bắc Ninh 3
Bến Tre 3
Can Tho 3
Clifton 3
Dhaka 3
Düsseldorf 3
Grafing 3
Guayaquil 3
Guwahati 3
Totale 4.136
Salva come PNG Salva come JPEG
Nome #
Cabozantinib in the treatment of advanced renal cell carcinoma : Design, development, and potential place in the therapy 322
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma? 268
Targeted treatments in advanced renal cell carcinoma : focus on Axitinib 262
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma 257
Clinical impact of Pancreatic metastases from renal cell carcinoma : A multicenter retrospective analysis 253
Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors : implications for clinical practice, trial design, and molecular interrogation 229
Rationale and protocol of RESORT, a randomized, open-label, multicenter phase II study to evaluate the efficacy of sorafenib in patients with advanced renal cell carcinoma after radical resection of the metastases 218
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21) 217
Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors 211
Biomarker-driven immunotherapy for precision medicine in prostate cancer 199
Safety profile and treatment response of everolimus in different solid tumors : an observational study 198
Treatment of collecting duct carcinoma : current status and future perspectives 193
Butterfly and renal cell cancer : Out of chaos comes order 186
Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma : a systematic review and meta-analysis of literature data 186
Safety of abiraterone acetate in castration-resistant prostate cancer patients with concomitant cardiovascular risk factors 184
Immunotherapy advances in uro-genital malignancies 182
From biology to clinical experience : evolution in the knowledge of neuroendocrine tumours 181
Time from nephrectomy as a prognostic factor in metastatic renal cell carcinoma patients receiving targeted therapies : overall results from a large cohort of patients 171
Study design and clinical evidence in mRCC : can we save axitinib as a first-line therapy? 170
Patient approach in advanced/metastatic renal cell carcinoma : focus on the elderly population and treatment-related toxicity 169
Sequential Tyrosine Kinase Inhibitors (TKIs) in metastatic renal cell carcinoma : results from a large cohort of patients 168
Sites of disease as predictors of outcome in metastatic renal cell carcinoma patients treated with first-line sunitinib or sorafenib 165
Inhibition of the VEGF/VEGFR pathway improves survival in advanced kidney cancer : a systematic review and meta-analysis 165
Treatment of elderly patients with metastatic renal cell carcinoma 165
Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients 149
First line treatment of metastatic renal cell carcinoma : two standards with different toxicity profile 148
Rationale and protocol of SOAP : A phase II study to evaluate the efficacy of Sorafenib as second-line treatment after pazopanib in patients with advanced renal cell carcinoma 141
Management of advanced genitourinary tumors 137
Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents 120
Prognostic role of pancreatic metastases from renal cell carcinoma : Results from an Italian center 81
Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program 71
Targeted therapies and survival: What we can learn from studies in advanced renal cell carcinoma 69
Everolimus treatment for neuroendocrine tumors: latest results and clinical potential 63
Totale 5.898
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.835
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.835
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 0 0 0 0 11 8 14
2021/2022276 15 12 8 7 9 12 11 22 14 29 12 125
2022/2023527 52 93 61 65 33 84 17 25 63 6 26 2
2023/20241.025 5 23 29 6 95 9 160 161 67 148 162 160
2024/20251.135 138 133 111 177 64 30 11 62 35 81 68 225
2025/20261.604 210 105 143 168 231 106 326 51 169 95 0 0
Totale 5.898